Monoclonal Antibody Diagnostic Reagents Market, By Diagnostic Tests (Double Antigen Sandwich Chemiluminescence Method, Dot-immunogold Filtration Assay, and Recombinant Immunoblot Assay, Enzyme Linked Immunosorbent Assay), By Application (Tumor Monitoring, Hormones Diagnosis, Virus Detection, and Others) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) - Trends, Analysis and Forecast till 2034

Monoclonal Antibody Diagnostic Reagents Market was valued at US$ 8.5 billion in 2024 and is projected to grow at a CAGR of 12.3% to reach US$ 27.2 billion by 2034.

Antibodies are an essential tool for many applications including flow cytometric analysis, immunoprecipitation, enzyme-linked immunosorbent assay (ELISA), immunocytochemistry, western blotting, and immunohistochemistry. Moreover, monoclonal antibodies (MAbs) are significant diagnostic reagent used in microbiological research, biomedical research, and also in diagnosis of various diseases such as HIV, hepatitis, herpes simplex, influenza infections, chlamydia, as well as for the treatment of cancer. Therefore, due to its importance in the clinical application, it is expected to boost the Monoclonal Antibody Diagnostic Reagents Market growth during the forecast period.

Monoclonal antibodies diagnostic reagent is routinely used in radioimmunoassay and enzyme-linked immunosorbent assays in laboratories. Further, these assays measure the circulating concentration of hormones and cell products. Thus, owing to its broad application, the Monoclonal Antibody Diagnostic Reagents Market will gain more share value in the coming years.

                      For More Report Details, Download Free Sample PDF

Presently, the rising prevalence of diseases and infections is a major driving factor driving the global market. Additionally, increasing research & developmental activity in the diagnostic field is likely to act as a growth engine for the global market.

However, high cost and need of considerable time may hinder the monoclonal antibody diagnostic reagents market growth within the forecast period.

Monoclonal Antibody Diagnostic Reagents Market is segmented on the basis of Diagnostic tests, Application, and Region.

The diagnostic test type segment includes a double antigen sandwich chemiluminescence method, dot-immunogold filtration assay, and recombinant immunoblot assay, enzyme-linked immunosorbent assay.

On the basis of application, the monoclonal antibody diagnostic reagents market is segmented into tumor monitoring, hormones diagnosis, virus detection, and others.

Regional Insights:

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

On the basis of region, the target market has been segmented into North America, Latin America, Asia Pacific, Europe, Middle East and Africa. North America is expected to account major market share as compared to that of other regions.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the Monoclonal Antibody Diagnostic Reagents Market report based on diagnostic tests, application, and region.:

Monoclonal Antibody Diagnostic Reagents Market , By Diagnostic Tests:

• Double Antigen Sandwich Chemiluminescence Method
• Dot-immunogold Filtration Assay
• Recombinant Immunoblot Assay
• Enzyme Linked Immunosorbent Assay

Monoclonal Antibody Diagnostic Reagents Market , By Application:

• Tumor Monitoring
• Hormones Diagnosis
• Virus Detection
• Others

Monoclonal Antibody Diagnostic Reagents Market , By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the Monoclonal Antibody Diagnostic Reagents Market includes AnaSpec, Bio-Rad, BioGenex, BioVision,  Biocare Medical, Creative Diagnostics, GenWay Biotech, Celltrion, MedixBiochemica, Innovent Biologics, Qiagen, and Teva Pharmaceutical Ltd.

• Bio-Rad*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• AnaSpec
• BioGenex
• BioVision
• Biocare Medical
• Creative Diagnostics
• GenWay Biotech
• Celltrion
• MedixBiochemica
• Innovent Biologics
• Qiagen
• Teva Pharmaceutical Ltd.

“*” marked represents similar segmentation in other categories in the respective section.